SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS)
IONS 71.53+2.4%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott H. Davis who wrote (2069)7/7/1998 10:42:00 AM
From: sds  Read Replies (2) of 4676
 
Protease and the new CMV,

Scott, I don't know what to make of the new info. Ya know, they talk about PI resistance, but I haven't heard any specific side-effects mentioned. I would THINK that CMV-retinitis would go hand-in-hand with the PI resistance, but I haven't seen info. to support that. Have you?

Here's my emerging take on CMV -- who cares? Whether it is $100 million, $200 million, or $300 million, it doesn't really matter. Either way, this won't be THE drug that makes Isis worth owning.

You are very right about the Isis administration -- you can't forget. Also, from what I hear, the injection is actually not very painful and some people prefer it to pills (I guess if I were swallowing 12 pills a day, a poke in the eye might not seem so bad).

In any case, I'm glad to see Isis get a drug out, but I'm still concerned about the pipeline and its translation into money.

sds

P.S. Got a question, and MZ is probably the best to ask -- how/why is it that a drug that treats Crohn's will usually have some effect with R.Arthritis (and vice versa). Are the both affected by the same ICAM?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext